Found 0 matching trials
A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer PHASE4 This study will evaluate the efficacy, safety, and pharmacoeconomics of ora...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine PHASE2 Capecitabine is a chemotherapy drug used to treat many types of cancer incl...
Show More Location
Edinburgh Cancer Centre
Learn More & Join Trial
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) PHASE2 The goal of this research study is to compare a combination of two drugs, c...
Show More Location
Dana-Farber Cancer Institute
Learn More & Join Trial
A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients PHASE2 This is a randomized, open-label, active-control, multi-center, phase IIb/I...
Show More Learn More & Join Trial
Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer PHASE2 Subjects with advanced or metastatic (spread to other parts of the body) br...
Show More Location
Rutgers Cancer Institute of New Jersey at Hamilton
Learn More & Join Trial
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer PHASE3 This is a Phase III, 2-arm, randomised, open-label, multicentre, global stu...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer PHASE3 This study evaluates whether sequential neo-adjuvant chemotherapy plus surg...
Show More Location
the First Hospital of Jilin University
Learn More & Join Trial
MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer PHASE2 This research study is for people who have pancreas cancer for which surger...
Show More Status
Active Not Recruiting
Location
Froedtert Hospital
Learn More & Join Trial
To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older PHASE3 The main purpose of this study is to compare treatment with either pegylate...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer PHASE3 The purpose of this study is to evaluate two study medicines (encorafenib p...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital
Learn More & Join Trial